Yi-Hang Wu
- Pharmacology top 2%
- Drug-Induced Hepatotoxicity and Protection 10
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 4
- MicroRNA in disease regulation 3
- Biochemistry top 10%
- Hepatology top 10%
- Liver physiology and pathology 5
-
- Hepatitis B Virus Studies 7
- Liver Disease Diagnosis and Treatment 3
-
- Natural product bioactivities and synthesis 3
- Heme Oxygenase-1 and Carbon Monoxide 3
Yi-Hang Wu
30 papers receiving 965 citations
Peers
Comparison fields: 5 of 110
- Pharmacology 179
- Cancer Research 275
- Complementary and alternative medicine 87
- Biochemistry 59
- Hepatology 74
Countries citing papers authored by Yi-Hang Wu
This map shows the geographic impact of Yi-Hang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi-Hang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi-Hang Wu more than expected).
Fields of papers citing papers by Yi-Hang Wu
This network shows the impact of papers produced by Yi-Hang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi-Hang Wu. The network helps show where Yi-Hang Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yi-Hang Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 21 | |
| 3 | 2023 | 3 | |
| 4 | 2022 | 8 | |
| 5 | 2019 | 72 | |
| 6 | 2018 | 125 | |
| 7 | 2018 | 65 | |
| 8 | 2015 | 39 | |
| 9 | 2015 | 5 | |
| 10 | 2014 | 27 | |
| 11 | 2014 | 40 | |
| 12 | 2014 | 92 | |
| 13 | 2012 | 9 | |
| 14 | 2012 | 61 | |
| 15 | 2012 | 29 | |
| 16 | 2011 | 4 | |
| 17 | 2009 | 25 | |
| 18 | 2006 | 50 | |
| 19 | 2006 | 67 | |
| 20 | 2006 | 37 |
About Yi-Hang Wu
Yi-Hang Wu is a scholar working on Pharmacology, Hepatology and Cancer Research, having authored 31 papers that have together received 1.0k indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (10 papers), Hepatitis B Virus Studies (7 papers), Liver physiology and pathology (5 papers), Cancer-related molecular mechanisms research (4 papers), Liver Disease Diagnosis and Treatment (3 papers), MicroRNA in disease regulation (3 papers), Natural product bioactivities and synthesis (3 papers) and Heme Oxygenase-1 and Carbon Monoxide (3 papers). The work is most often cited by research in Pharmacology (179 citations), Cancer Research (275 citations) and Complementary and alternative medicine (87 citations). Yi-Hang Wu has collaborated with scholars based in China, Taiwan and France. Frequent co-authors include Lipeng Qiu, Rongfa Guan, Yu Zhao, Qi Tang, Keping Chen, Xiumei Wu, Chang‐Xin Zhou, Jie Tong, Chi Chen and Hui Fu. Their work appears in journals such as International Journal of Molecular Sciences, Journal of Ethnopharmacology and Organic Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.